India Glycols Ltd

India Glycols Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

India Glycols Ltd

₹ 1,786 1.22%
08 Aug 10:49 a.m.
indiaglycols.com BSE: 500201 NSE: INDIAGLYCO
About

Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals. [1][2]

Key Points

Business Segments [1]

Website BSE NSE
  • Market Cap ₹ 5,529 Cr.
  • Current Price ₹ 1,786
  • High / Low ₹ 2,139 / 1,005
  • Stock P/E 29.6
  • Book Value ₹ 604
  • Dividend Yield 0.43 %
  • ROCE 11.9 %
  • ROE 10.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 19.0%
  • Debtor days have improved from 46.2 to 35.5 days.

Cons

  • Stock is trading at 2.93 times its book value
  • The company has delivered a poor sales growth of 6.78% over past five years.
  • Company has a low return on equity of 8.82% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Breweries & Distilleries

Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
808 670 553 619 688 775 904 924 968 961 975 863 1,040
745 604 481 522 592 681 801 818 846 845 851 719 893
Operating Profit 63 66 72 97 95 94 103 105 123 116 124 144 148
OPM % 8% 10% 13% 16% 14% 12% 11% 11% 13% 12% 13% 17% 14%
7 8 -9 4 6 11 5 5 3 4 6 2 1
Interest 20 23 26 26 28 29 31 33 36 40 44 45 45
Depreciation 20 20 20 29 21 28 26 26 28 28 27 33 34
Profit before tax 30 30 17 46 53 48 50 51 62 53 58 68 70
Tax % 24% 26% 19% 13% 24% 25% 24% 26% 25% 26% 25% 26% 25%
23 22 13 40 41 36 38 38 47 39 44 50 53
EPS in Rs 7.37 7.26 4.31 12.95 13.09 11.52 12.21 12.19 15.10 12.74 14.16 16.26 17.07
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
2,885 2,557 2,322 2,473 3,028 3,356 2,714 2,280 2,863 2,650 3,291 3,767 3,839
2,674 2,420 2,140 2,237 2,703 2,936 2,436 2,022 2,611 2,353 2,893 3,260 3,307
Operating Profit 211 137 182 237 325 420 278 258 252 298 398 507 532
OPM % 7% 5% 8% 10% 11% 13% 10% 11% 9% 11% 12% 13% 14%
-164 -15 -50 7 10 17 52 34 237 10 25 15 13
Interest 134 158 133 122 118 136 90 73 62 95 121 164 173
Depreciation 83 81 65 68 69 72 73 76 76 90 101 115 122
Profit before tax -170 -117 -66 54 149 229 166 143 352 123 202 242 250
Tax % -30% -47% -36% 17% 34% 35% 23% 41% 19% 20% 25% 25%
-120 -61 -42 45 98 148 128 84 285 99 152 180 186
EPS in Rs -38.61 -19.81 -13.67 14.38 31.68 47.87 41.43 27.23 92.18 31.89 49.01 58.26 60.23
Dividend Payout % -3% 0% 0% 7% 13% 13% 14% 22% 8% 24% 16% 17%
Compounded Sales Growth
10 Years: 4%
5 Years: 7%
3 Years: 10%
TTM: 7%
Compounded Profit Growth
10 Years: 35%
5 Years: 7%
3 Years: 14%
TTM: 18%
Stock Price CAGR
10 Years: 32%
5 Years: 45%
3 Years: 29%
1 Year: 49%
Return on Equity
10 Years: 9%
5 Years: 9%
3 Years: 9%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 31 31 31 31 31 31 31 31 31 31 31 31
Reserves 475 424 771 815 910 1,043 1,127 1,214 1,481 1,557 1,685 1,840
1,927 2,138 1,120 977 766 930 928 1,064 969 1,112 1,348 1,892
776 564 1,555 1,540 1,637 1,711 1,941 1,765 1,787 1,844 2,217 2,028
Total Liabilities 3,209 3,158 3,478 3,363 3,345 3,715 4,027 4,074 4,267 4,543 5,281 5,790
1,188 1,032 1,917 2,003 2,053 2,074 2,134 2,102 2,232 2,717 3,205 3,829
CWIP 122 142 167 78 76 124 163 119 237 125 84 98
Investments 57 82 29 26 26 26 29 29 29 2 0 0
1,841 1,901 1,365 1,257 1,190 1,491 1,702 1,824 1,770 1,700 1,993 1,863
Total Assets 3,209 3,158 3,478 3,363 3,345 3,715 4,027 4,074 4,267 4,543 5,281 5,790

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-138 -154 1,223 302 487 148 344 142 114 326 438 362
2 155 -79 -41 -145 -133 -156 -157 77 -330 -503 -736
106 -1 -1,161 -261 -342 7 -212 16 -188 -0 90 354
Net Cash Flow -30 -1 -17 1 0 22 -24 0 4 -5 25 -20

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 56 62 59 59 41 36 77 58 51 60 43 35
Inventory Days 106 107 124 129 87 123 147 168 147 209 223 177
Days Payable 91 55 117 145 152 142 156 162 137 209 223 148
Cash Conversion Cycle 71 115 66 43 -24 18 69 65 61 60 44 64
Working Capital Days -38 -87 -81 -103 -61 -33 -44 -58 -14 -45 -63 -57
ROCE % 6% 4% 6% 9% 15% 20% 13% 9% 8% 9% 11% 12%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
61.02% 61.02% 61.02% 61.02% 61.02% 61.02% 61.02% 61.02% 61.02% 61.02% 61.02% 61.02%
1.31% 1.22% 1.17% 1.16% 1.29% 1.57% 1.80% 1.75% 2.90% 2.44% 2.24% 3.44%
3.76% 3.75% 4.17% 1.97% 0.06% 0.11% 0.08% 0.09% 1.93% 2.00% 0.91% 1.39%
33.92% 34.00% 33.64% 35.86% 37.63% 37.30% 37.11% 37.15% 34.15% 34.54% 35.82% 34.15%
No. of Shareholders 43,15942,82342,86943,85347,47647,25959,57957,76854,75162,40859,73655,149

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls